13 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 32075117 | Chronic Cannabidiol Administration Fails to Diminish Blood Pressure in Rats with Primary and Secondary Hypertension Despite Its Effects on Cardiac and Plasma Endocannabinoid System, Oxidative Stress and Lipid Metabolism. | 2020 Feb 14 | 1 |
2 | 30251159 | Effects of fatty acid amide hydrolase inhibitor URB597 in a rat model of trauma-induced long-term anxiety. | 2018 Nov | 4 |
3 | 26642910 | Decreased anxiety in juvenile rats following exposure to low levels of chlorpyrifos during development. | 2017 Mar | 1 |
4 | 24433863 | Heteroarylureas with spirocyclic diamine cores as inhibitors of fatty acid amide hydrolase. | 2014 Feb 1 | 2 |
5 | 25245162 | FAAH-mediated modulation of TLR3-induced neuroinflammation in the rat hippocampus. | 2014 Nov 15 | 1 |
6 | 23573230 | Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism. | 2013 | 1 |
7 | 22029844 | The cytoprotective effects of oleoylethanolamide in insulin-secreting cells do not require activation of GPR119. | 2012 Apr | 5 |
8 | 20801430 | Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors. | 2011 Apr 1 | 2 |
9 | 21779318 | Administration of URB597, oleoylethanolamide or palmitoylethanolamide increases waking and dopamine in rats. | 2011 | 2 |
10 | 20353771 | Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain. | 2010 Jul | 1 |
11 | 19403796 | Fatty acid amide hydrolase (FAAH) inhibition enhances memory acquisition through activation of PPAR-alpha nuclear receptors. | 2009 May | 4 |
12 | 17336288 | Effects of the fatty acid amide hydrolase inhibitor URB597 on the sleep-wake cycle, c-Fos expression and dopamine levels of the rat. | 2007 May 7 | 3 |
13 | 12773040 | Design, synthesis, and structure-activity relationships of alkylcarbamic acid aryl esters, a new class of fatty acid amide hydrolase inhibitors. | 2003 Jun 5 | 1 |